BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1707866)

  • 1. Dimethyl sulfoxide inhibits human immunodeficiency virus production in vitro.
    Viza D; Aranda-Anzaldo A; Zompetti C; Vich JM
    Intervirology; 1991; 32(1):59-64. PubMed ID: 1707866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alcohol on HIV infection in vitro.
    Saravolatz LD; Cerra RF; Pohlod DJ; Smereck S
    Prog Clin Biol Res; 1990; 325():267-71. PubMed ID: 2105508
    [No Abstract]   [Full Text] [Related]  

  • 3. Muramyl dipeptide inhibits replication of human immunodeficiency virus in vitro.
    Masihi KN; Lange W; Rohde-Schulz B; Chedid L
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):393-9. PubMed ID: 2111159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of HIV-1 marker detection in cell cultures treated with mild heat-shock.
    Furlini G; Re MC; Musiani M; Zerbini ML; La Placa M
    Microbiologica; 1990 Jan; 13(1):21-6. PubMed ID: 1689802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
    Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
    J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV replication in lymphocyte cultures of virus-positive subjects in the presence of sho-saiko-to, an oriental plant extract.
    Buimovici-Klein E; Mohan V; Lange M; Fenamore E; Inada Y; Cooper LZ
    Antiviral Res; 1990; 14(4-5):279-86. PubMed ID: 1708225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV replication by naphthalenemonosulfonic acid derivatives and a bis naphthalenedisulfonic acid compound.
    Mohan P; Singh R; Wepsiec J; Gonzalez I; Sun DK; Sarin PS
    Life Sci; 1990; 47(12):993-9. PubMed ID: 2122146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
    Masquelier B; Combeau T; Poveda JD; Delord B; Pellegrin JL; Sallafranque-Andreola ML; Tarrago-Litvak L; Fleury HJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):499-505. PubMed ID: 1707962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
    Sundqvist VA; Albert J; Ohlsson E; Hinkula J; Fenyö EM; Wahren B
    J Med Virol; 1989 Nov; 29(3):170-5. PubMed ID: 2482339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle.
    Collette Y; Olive D
    Virology; 1999 Dec; 265(2):173-7. PubMed ID: 10600589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
    von der Helm K; Gürtler L; Eberle J; Deinhardt F
    FEBS Lett; 1989 Apr; 247(2):349-52. PubMed ID: 2469601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 13. MAP 30: a new inhibitor of HIV-1 infection and replication.
    Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
    FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.
    Haynes JR; Cao SX; Rovinski B; Sia C; James O; Dekaban GA; Klein MH
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):17-27. PubMed ID: 1707639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of nonproductive human immunodeficiency virus type 1 infection of human fetal dorsal root ganglia glial cells.
    Kunsch C; Wigdahl B
    Intervirology; 1990; 31(2-4):147-58. PubMed ID: 1695619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
    Smith MS; Thresher RJ; Pagano JS
    Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of human immunodeficiency viral replication by pine cone extracts.
    Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells].
    Schmidtmayerová H; Mayer V
    Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT.
    Williams GJ; Colby CB
    J Interferon Res; 1989 Dec; 9(6):709-18. PubMed ID: 2514233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus.
    Zhu ZH; Chen SS; Huang AS
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):215-9. PubMed ID: 2154577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.